Swiss authorities grant product approval for Intercell's IXIARO
Vaccine to help prevent Japanese Encephalitis now available in Switzerland
Intercell AG announced that Swissmedic has approved IXIARO®,its vaccine against Japanese encephalitis. IXIARO®, which is distributed and marketed by Novartis, is now available in Switzerland.
The decision by the Swiss authorities represents another important milestone for the licensure process initiated for selected attractive market segments. Intercell's vaccine, which helps to prevent Japanese Encephalitis, has already been approved and launched in the USA, Europe, Canada and Australia.
"The Swissmedic approval is great news and another important step in the product's global reach", states Thomas Lingelbach, Chief Operating Officer of Intercell.
IXIARO® is a modern purified, inactivated vaccine for active immunization of adults against infections caused by the Japanese Encephalitis Virus. IXIARO®is manufactured at Intercell's proprietary manufacturing facility in Scotland using tissue culture rather than live organisms.
Most read news
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
UCLA scientists map all mammalian gene interactions

How molecules measure embryo size
Cramp
Calcidiol
Temple_(anatomy)

A new contrast agent for MRI - New iron oxide nanoparticles could help avoid a rare side effect caused by current contrast agents
DNA-coated nanotubes help kill tumors without harm to surrounding tissue
RETSCH relocates to new, larger premises
Sensitive new assay detects hepatitis B infection in single liver cells and serum
International_Osteoporosis_Foundation
Prion disease detected soon after infection and in surprising place in mouse brains
